Austin L Chien
Overview
Explore the profile of Austin L Chien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
502
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chien A, Chua K, Doppalapudi S, Ghodoussipour S
Front Urol
. 2024 Jun;
2.
PMID: 38855025
Upper tract urothelial carcinoma (UTUC) has traditionally been managed with radical nephroureterectomy, and while this approach remains the gold standard for high-risk disease, endoscopic, kidney-sparing management has increasingly been adopted...
2.
Chien A, Doppalapudi S, Pfail J, Lee G, Mikhail M, Ahuja B, et al.
J Endourol
. 2023 Oct;
38(1):47-52.
PMID: 37819689
Conventional operative insufflation uses a one-way trocar to handle instruments while maintaining pneumoperitoneum. In 2007, the AirSeal valveless trocar insufflation system was introduced, which maintains stable pneumoperitoneum while continuously evacuating...
3.
Saifuddin A, Chien A, Shah K, Bodner L, Nosher J, Kang F
J Vasc Interv Radiol
. 2023 Feb;
34(6):1087-1089.
PMID: 36791955
No abstract available.
4.
Thompson J, Carpenter E, Silva B, Rosenstein J, Chien A, Quinn K, et al.
JCO Precis Oncol
. 2021 Jun;
5.
PMID: 34095713
Materials And Methods: Patients with mNSCLC receiving pembrolizumab monotherapy or in combination with chemotherapy underwent a 74-gene next-generation sequencing panel on blood samples obtained at baseline and at 9 weeks....
5.
Yousefi B, LaRiviere M, Cohen E, Buckingham T, Yee S, Black T, et al.
Sci Rep
. 2021 May;
11(1):9984.
PMID: 33976268
Among non-small cell lung cancer (NSCLC) patients with therapeutically targetable tumor mutations in epidermal growth factor receptor (EGFR), not all patients respond to targeted therapy. Combining circulating-tumor DNA (ctDNA), clinical...
6.
Thaker A, Chien A, Dubroff J
PET Clin
. 2020 Nov;
16(1):137-146.
PMID: 33160927
Since its inception, PET imaging of the nervous system and neuropsychiatric disease has focused on the brain. Although this has resulted in many important contributions to basic science and clinical...
7.
Aggarwal C, Thompson J, Chien A, Quinn K, Hwang W, Black T, et al.
Clin Cancer Res
. 2020 Feb;
26(10):2354-2361.
PMID: 32102950
Purpose: The role of plasma-based tumor mutation burden (pTMB) in predicting response to pembrolizumab-based first-line standard-of-care therapy for metastatic non-small cell lung cancer (mNSCLC) has not been explored. Experimental Design:...
8.
Lee J, Stone M, Porrett P, Thomas S, Komar C, Li J, et al.
Nature
. 2019 Mar;
567(7747):249-252.
PMID: 30842658
The liver is the most common site of metastatic disease. Although this metastatic tropism may reflect the mechanical trapping of circulating tumour cells, liver metastasis is also dependent, at least...
9.
Aggarwal C, Thompson J, Black T, Katz S, Fan R, Yee S, et al.
JAMA Oncol
. 2018 Oct;
5(2):173-180.
PMID: 30325992
Importance: The clinical implications of adding plasma-based circulating tumor DNA next-generation sequencing (NGS) to tissue NGS for targetable mutation detection in non-small cell lung cancer (NSCLC) have not been formally...